Cargando…
Recent Development of pH-Responsive Polymers for Cancer Nanomedicine
Cancer remains a leading cause of death worldwide with more than 10 million new cases every year. Tumor-targeted nanomedicines have shown substantial improvements of the therapeutic index of anticancer agents, addressing the deficiencies of conventional chemotherapy, and have had a tremendous growth...
Autores principales: | Tang, Houliang, Zhao, Weilong, Yu, Jinming, Li, Yang, Zhao, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337262/ https://www.ncbi.nlm.nih.gov/pubmed/30577475 http://dx.doi.org/10.3390/molecules24010004 |
Ejemplares similares
-
Smart pH-responsive nanomedicines for disease therapy
por: Shinn, Jongyoon, et al.
Publicado: (2022) -
Strategies for the Development of pH-Responsive Synthetic Polypeptides and Polymer-Peptide Hybrids: Recent Advancements
por: Dharmayanti, Cintya, et al.
Publicado: (2021) -
Polycarbonate-based ultra-pH sensitive nanoparticles improve therapeutic window
por: Wang, Xu, et al.
Publicado: (2020) -
Smart nanomedicine agents for cancer, triggered by pH, glutathione, H(2)O(2), or H(2)S
por: Li, Yaping, et al.
Publicado: (2019) -
Recent Developments in Nanomedicine for Pediatric Cancer
por: Yang, Shicheng, et al.
Publicado: (2021)